Consequently, it is widely admitted that PERK’s action initially favors cancer progression by preventing cancer cell death, as was supported by pioneering studies on the effect of PERK knockout on the in vivo growth of tumors in mice models [83,84]. This evidence concerns the gene EIF2AK3 and cancer.